Monitoring antimicrobial resistance in Neisseria gonorrhoeae in selected countries of the WHO South-East Asia Region between 2009 and 2012: A retrospective analysis

Sexually Transmitted Infections

Volumn 89, Issue SUPPL. 4, 2013, Pages

  Bala, Manju ^a   Kakran, Monika ^a   Singh, Vikram ^a   Sood, Seema ^b   Ramesh, V ^a  

^a SAFDARJUNG HOSPITAL   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFPODOXIME; CEFTRIAXONE; CIPROFLOXACIN; PENICILLIN DERIVATIVE; SPECTINOMYCIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; EPSILOMETER TEST; FEMALE; GONORRHEA; HEALTH SURVEY; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA; NEISSERIA GONORRHOEAE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RETROSPECTIVE STUDY; SEXUALLY TRANSMITTED DISEASE; WORLD HEALTH ORGANIZATION;

ANTIBIOTIC RESISTANCE; NEISSERIA GONORRHOEA; SURVEILLANCE; SYNDROMIC MANAGEMENT;

ANIMALS; ANTI-BACTERIAL AGENTS; ASIA, SOUTHEASTERN; DRUG RESISTANCE, BACTERIAL; EPIDEMIOLOGICAL MONITORING; FEMALE; GONORRHEA; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; NEISSERIA GONORRHOEAE; PREVALENCE; RETROSPECTIVE STUDIES; WORLD HEALTH ORGANIZATION;

EID: 84891852867     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sextrans-2012-050904     Document Type: Article

References (27)

1. World Health Organization. Global surveillance network for gonococcal antimicrobial susceptibility. Geneva: World Health Organization, 1990, WHO/VDT/90-452.
2. Ray K, Bala M, Kumar J, et al. Trend of antimicrobial resistance in N. gonorrhoeae at New Delhi, India. Int J STD AIDS 2000;11:115-18. (Pubitemid 30081615)
3. Bala M, Ray K, Kumari S. Alarming increase in ciprofloxacin and penicillin resistant Neisseria gonorrhoeae isolates in New Delhi, India. Sex Transm Dis 2003;30:523-5. (Pubitemid 36667034)
4. Ray K, Bala M, Kumari S, et al. Antimicrobial resistance of Neisseria gonorrhoeae in selected World Health Organisation Southeast Asia Region countries: An overview. Sex Transm Dis 2005;32:178-84. (Pubitemid 40271271)
5. Bala M, Ray K, Gupta SM, et al. Changing trends of antimicrobial susceptibility pattern of Neisseria gonorrhoeae in India and the emergence of ceftriaxone less susceptible N. gonorrhoeae strains. J Antimicrob Chemother 2007;60:582-6. (Pubitemid 47299872)
6. Chaudhary C, Hasan C, Faisal A, et al. A pilot study on antimicrobial susceptibility of Neisseria gonorrhoeae isolates from Nepal. Sex Transm Dis 2005;32:641-3. (Pubitemid 41429187)
7. Ahmed MU, Chawdhury FAH, Hossain M, et al. Monitoring antimicrobial susceptibility of Neisseria gonorrhoeae isolated from Bangladesh during 1997-2006: Emergence and pattern of drug-resistant isolates. J Health Population Nutrition 2010;28:443-9.
8. Bala M. Antimicrobial resistance in Neisseria gonorrhoeae in South-East Asia. WHO South-East Asia Regional Health Forum 2011;15:63-73.
9. WHO Western Pacific and South East Asian Gonococcal Antimicrobial Surveillance Programmes. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific and South East Asian regions, 2007-2008. Commun Dis Intell 2010;34:1-7.
10. WHO Western Pacific and South East Asian Gonococcal Antimicrobial Surveillance Programmes. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific and South East Asian regions, 2009. Commun Dis Intell 2011;35:1-6.
11. WHO Western Pacific and South East Asian Gonococcal Antimicrobial Surveillance Programmes. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific and South East Asian regions, 2010. Commun Dis Intell 2012;36:95-100.
12. Ndowa F, Lusti-Narasimhan M, Unemo M. The serious threat of multidrug-resistant and untreatable gonorrhoea: The pressing need for global action to control the spread of antimicrobial resistance, and mitigate the impact on sexual and reproductive health. Sex Transm Infect 2012;88:317-18.
13. World Health Organization (WHO). Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. Geneva: Department of Reproductive Health and Research WHO, 2012:P1-36. http://www.who.int/reproductivehealth/publications/rtis/9789241503501 (accessed 24 Mar 2013).
14. Laboratory diagnosis of gonorrhoea. WHO regional publication, South East Asia series no 33. Geneva: World Health Organisation, 1999. http://w3.whosea. org/book33 (accessed 24 Mar 2013).
15. Tapsall JW. Antimicrobial testing and applications in the pathogenic Neisseria. In: Merlino J, ed Antimicrobial susceptibility testing: Methods and practices with an Australian perspective. Sydney: Australian Society for Microbiology, 2004:P175-88.
16. Bell SM, Pham JN, Fisher GT. Antibiotic susceptibility testing by the CDS method. A manual for medical and veterinary laboratories. Fifth edition. 2009;P42-58. http://web.med.unsw.edu.au/cdstest (accessed 24 Mar 2013).
17. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. Seventeenth Informational Supplement. CLSI document M100-S17. Wayne, USA: Clinical and Laboratory Standards Institute, 2007.
18. Tapsall JW, Ndowa F, Lewis DA, et al. Meeting the public health challenge of multiand extensively-drug resistant Neisseria gonorrhoeae. Expert Rev Anti Infect Ther 2009;7:821-34.
19. Bala M, Tapsall JW, Limnios A, et al. Experience with an external quality assurance scheme for antimicrobial susceptibility testing of Neisseria gonorrhoeae in India, 2001-2007. Epidemiol Infect 2010;138:69-75.
20. Starnino S, GASP-LAC Working Group, Galarza P, Carvallo ME, et al. Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone. Sex Transm Dis 2012;39:813-21.
21. Kubanova A, Frigo N, Kubanov A, et al. The Russian gonococcal antimicrobial susceptibility programme (RU-GASP)-national resistance prevalence in 2007 and 2008, and trends during 2005-2008. Euro Surveill 2010;15:pii=19533. http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId=19533 (accessed 28 Mar 2013).
22. Cole MJ, Unemo M, Hoffmann S, et al. The European gonococcal antimicrobial surveillance programme, 2009. Euro Surveill 2011;16:pii:19995.
23. Lewis DA. Antimicrobial-resistant gonorrhoea in Africa: An important public health threat in need of a regional gonococcal antimicrobial surveillance programme. South Afr J Epidemiol Infect 2011;26:215-20.
24. Health Protection Agency. GRASP 2011 Report: The Gonococcal Resistance to Antimicrobials Surveillance Programme. Health Protection Agency Report, 2012.
25. Ohnishi M, Golparian D, Shimuta K, et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: Detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother 2011;55:3538-45.
26. Unemo M, Golparian D, Nicholas R, et al. High-level cefixime-and ceftriaxone-resistant Neisseria gonorrhoeae in France: Novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother 2012;56:1273-80.
27. Camara J, Serra J, Ayats J, et al. Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain. J Antimicrob Chemother 2012;67:1858-60.